The analysis, led by Yafei Fan, Weiwei Zhang, Yue Jiang and Mingyang Xing of East China University of Science and Technology together with colleagues Wenjie Lv, Minghui Zhu and Pengbo Fu, lays out a framework for what the authors call low-carbon advanced oxidation processes. Their central claim is provocative. After decades of innovation, contaminant removal efficiency in many systems is approaching its thermodynamic limits, meaning further gains in reaction kinetics deliver diminishing returns while escalating the environmental burden of the treatment itself. In a world racing to constrain carbon emissions, chasing kinetics alone has become, in their words, a paradox.

The logic behind that paradox is worth unpacking. Advanced oxidation processes work by generating reactive oxygen species, aggressive chemical intermediates such as hydroxyl radicals, sulfate radicals, singlet oxygen and high-valent metal-oxo species, that attack organic pollutants and ideally mineralize them completely to carbon dioxide, water and inorganic ions. Generating those species typically demands chemical inputs such as hydrogen peroxide, peroxymonosulfate or persulfate, along with energy for ultraviolet lamps, electrochemical cells, aeration or catalyst synthesis. Every kilogram of oxidant carries an embedded manufacturing footprint, every kilowatt-hour an emissions cost, and every spent catalyst or iron sludge a disposal problem. A treatment that destroys a micropollutant in minutes but consumes mountains of chemicals and electricity can therefore be worse for the climate than a slower, leaner alternative.

To resolve this, the team defines a low-carbon water treatment framework organized around the water–energy–carbon nexus and driven by three sustainability vectors: minimized chemical consumption, optimized energy inputs and solid waste valorization. Rather than treating these as afterthoughts to catalytic activity, the framework places them on equal footing with reaction performance. The shift reframes the design problem entirely. A next-generation oxidation process is no longer judged solely by how quickly it degrades a target compound, but by how much chemical, energy and waste it demands per unit of clean water delivered, and by what happens to everything it leaves behind.

The first vector, minimizing chemical consumption, is where atomic-scale chemistry is doing surprising work. Recent studies highlighted in the perspective show catalysts engineered to squeeze far more oxidative power out of far less oxidant. Single-atom catalysts, in which isolated metal atoms anchored on supports such as nitrogen-doped graphene or Ti3C2Tx MXene expose dual reaction sites, have achieved efficient Fenton-like catalysis with ultralow hydrogen peroxide doses. Metal oxyhalide-based systems reported in Nature Water in 2024 purified water with ultralow peroxide consumption, while nanoconfinement strategies have been shown to steer reactions toward nonradical pathways that improve oxidant utilization. Some dual-single-atom systems even drive oxidant-free Fenton-like chemistry, in which the catalyst architecture itself enables auto-catalytic cycles that barely need added reagents.

Selectivity is emerging as a twin strategy to dosage reduction. Traditional radical-based oxidation is indiscriminate: hydroxyl radicals attack whatever organic molecules they encounter, including natural organic matter that competes for the oxidant and wastes it. Newer catalyst designs, including metal-free dual-site systems that exclusively generate singlet oxygen and single-atom Mo–Co catalysts that selectively degrade high-ionization-potential pollutants with low biotoxicity, aim the oxidative power precisely at the contaminants that matter. The authors also point to a deeper conceptual question now gripping the field, crystallized in a 2024 Environmental Science & Technology commentary titled Mineralization or polymerization: that is the question. Rather than burning pollutants all the way to carbon dioxide, some systems deliberately steer degradation products into polymeric or coupled forms, opening the door to recovering carbon value instead of simply spending energy to destroy it.

The second vector, optimized energy, is producing some of the most eye-catching demonstrations. Piezocatalysis harvests mechanical energy from the natural motion of water itself, meaning turbulence in a pipe or flow through a treatment train can trigger Fenton-like reactions with no external electricity at all. Researchers have built self-powered systems in which water motion drives hydroxyl radical generation continuously, and have coupled piezoelectricity with advanced oxidation to produce hydrogen fuel from wastewater remediation, turning a treatment cost into an energy product. Photo-Fenton-like chemistry has been pushed toward aeration-free operation, and contact-electrocatalytic systems now degrade pollutants using low-frequency mechanical stirring energy. Even gas–liquid mass transfer, long overlooked in ozone-based processes, is being re-examined as a lever for efficiency, since bubbles that dissolve poorly waste the energy used to make them.

The third vector, solid waste valorization, tackles the embarrassing byproduct of conventional Fenton treatment: iron sludge. Instead of shipping it to landfill, the perspective documents a growing repertoire of circular approaches. Ferric sludge has been reused as an iron source for new Fenton cycles. Waste sewage sludge has been upcycled into high-performing single-atom Fenton-like catalysts, effectively converting a disposal liability into the very material that cleans the next batch of wastewater. Sludge-derived biochars activate hydrogen peroxide for dewatering and contaminant removal, iron-containing sludge systems activate peroxymonosulfate in situ to degrade emerging contaminants while improving sludge dewaterability, and solar-driven electroreforming of sludge can cogenerate green food and hydrogen. MoS2-based co-catalysts have even enabled resource recovery from Fenton sludge itself. In this vision, the treatment plant stops being an end-of-pipe remediation asset and becomes, as the authors put it, a core engine of circular regeneration and value creation.

Scaling these laboratory marvels is the next frontier, and the authors are candid about the gap between atomic elegance and industrial reality. They trace an evolution from atomic-level catalyst design to system-level process intensification, arguing that breakthroughs must now be matched by engineering that delivers them at scale. Encouraging signs include universal scalable production routes for single-atom catalysts reported in Nature Water in 2026, automated synthesis strategies with industrial compatibility, and large-scale deployment of single-atom catalysts within ceramic membranes and catalytic nanofiltration membranes for advanced water treatment. Process intensification also means rethinking reactors: nanoscale spatial confinement can accelerate heterogeneous Fenton kinetics, photothermal membranes can synergize light utilization for high-turbidity wastewater, and dual-substrate synergistic catalysis can activate pollutants and oxidants simultaneously on the same surface.

Digitalization forms the connective tissue of the proposed roadmap. Artificial intelligence is already reshaping the field, from cross-scale machine-learning frameworks that improve kinetic prediction and mechanistic coherence in Fenton chemistry, to data-driven discovery pipelines that accelerate the design and precise synthesis of single-atom catalysts, to multi-agent AI systems that autonomously design novel catalysts for ultrafast water purification. The authors envision AI-driven intelligent process control maintaining operational stability in real time, while embedding transformation process safety into system design, a nod to the risks that reactive oxygen chemistry can pose when processes drift outside their operating envelopes. Crucially, they propose that future technology evaluations formally incorporate life-cycle assessment and transformation risk metrics, so that a process’s carbon ledger and safety profile are weighed alongside its degradation kinetics from the very first paper to full deployment.

The timing of this reframing is not accidental. The wastewater sector is under intensifying scrutiny for its greenhouse gas footprint, with recent assessments documenting substantial emissions from treatment plants and persistent discrepancies in national inventories that reveal a large emissions gap. As global efforts to limit warming to 1.5 degrees Celsius continue to fall short, water infrastructure can no longer be designed as if energy and chemicals were free. The East China University of Science and Technology team’s framework, supported by China’s National Natural Science Foundation and National Key R&D Program, offers a structured, carbon-aware roadmap for next-generation water engineering. If it takes hold, the measure of a great water treatment technology will no longer be how fast it destroys a pollutant, but how little it costs the planet to do so, and how much value it returns in the process.

Subject of Research: Low-carbon redesign of advanced oxidation processes for sustainable water treatment

Article Title: Redefining advanced oxidation processes for low-carbon water treatment

Article References: Fan, Y., Zhang, W., Lv, W., Zhu, M., Fu, P., Jiang, Y., & Xing, M. (2026). Redefining advanced oxidation processes for low-carbon water treatment. Nature Water. https://doi.org/10.1038/s44221-026-00714-w

Image Credits: AI Generated

DOI: 10.1038/s44221-026-00714-w

Keywords: advanced oxidation processes, water treatment, low-carbon, reactive oxygen species, single-atom catalysts, Fenton chemistry, piezocatalysis, sludge valorization, life-cycle assessment, artificial intelligence, water–energy–carbon nexus, sustainability

The study, published in Nature Chemical Biology, describes a systematic pipeline in which human cells were treated with a library of small molecules while perturbing a broad panel of genes known to participate in genome maintenance. Each combination produced a measurable fitness signature—a fingerprint of viability, growth, and survival under stress. When those fingerprints were arranged into network form, they resolved into a chemogenomic map: a topological landscape in which drugs with similar mechanisms cluster together, and in which genes with related functions occupy neighboring positions. Such maps have proven their worth in cancer pharmacology before, where they revealed drug targets and resistance pathways that no one could have predicted from single-gene studies alone.

What makes the new analysis distinctive is its focus on the DNA damage response, the elaborate signaling network that detects broken strands of DNA, halts the cell cycle, coordinates repair machinery, and decides whether a damaged cell should live or die. Because so many cancer therapies—radiation, platinum drugs, topoisomerase inhibitors, PARP inhibitors—work by inflicting DNA damage, understanding the vulnerabilities and redundancies of this network is not an abstract scientific goal. It is a question that directly shapes treatment outcomes for millions of patients.

As the team clustered the chemical profiles, one signal kept surfacing. Compounds that disturb iron homeostasis—iron chelators that sequester the metal, and agents that expand the labile iron pool inside cells—produced genetic interaction patterns strikingly similar to compounds known to generate oxidative DNA damage. That convergence pointed to a mechanistic link: iron, through its well-documented role in Fenton chemistry, converts ordinary peroxide into hydroxyl radicals, the most destructive of the reactive oxygen species. Hydroxyl radicals attack DNA indiscriminately, producing strand breaks and oxidized bases that tax the same repair pathways mobilized by radiation and chemotherapy.

The linchpin of that link turned out to be peroxiredoxin 1, or PRDX1, a highly abundant enzyme whose canonical job is to detoxify peroxides inside the cell. Chemogenomic analysis showed that when PRDX1 function was compromised, cells became exquisitely sensitive to perturbations of iron metabolism. The map essentially revealed a dependency: iron-driven oxidative chemistry creates a peroxide burden, and PRDX1 is the gatekeeper that keeps that burden from escalating into lethal DNA damage. In cells with intact PRDX1, fluctuations in iron levels were tolerable; in cells lacking it, the same fluctuations translated into accumulating genome injury.

That discovery reframes PRDX1 from a general antioxidant housekeeper into a specific node of the DNA damage response. The enzyme, a member of the peroxiredoxin family of cysteine-based peroxidases, cycles between oxidized and reduced states as it destroys peroxide substrates. Its abundance in the nucleus and cytosol has long puzzled researchers—why does a cell need so much of it? The chemogenomic data suggest an answer in the language of vulnerability: PRDX1 provides the protective margin that allows cells to tolerate the continuous, low-level oxidative chemistry that accompanies normal metabolism, and that margin becomes decisive when DNA damage pushes iron-dependent radical production upward.

The iron-damage axis also has a darker face. In recent years, the cell biology community has converged on ferroptosis, a form of regulated cell death driven by iron-catalyzed lipid peroxidation, as a process with intimate ties to genome stress. The new map does not simply confirm that connection; it locates it within the broader architecture of the DNA damage response, showing that the same network that activates ATM and ATR kinases, deploys BRCA proteins, and summons the homologous recombination machinery is functionally coupled to peroxide metabolism and iron availability. Damage sensing and redox sensing, the map implies, are not separate systems but interlocking ones.

For oncology, the implications are immediately tantalizing. Many tumor types accumulate excess iron and rely heavily on antioxidant systems to survive their own metabolic output—a combination that makes them theoretically vulnerable to any therapy that removes their peroxide defense. If PRDX1 occupies that protective position in the iron-damage axis, then inhibiting it in an iron-rich tumor could tip the balance toward catastrophic, irreparable genome damage. Conversely, normal cells with lower labile iron loads might tolerate a PRDX1 inhibitor far better, creating the kind of therapeutic window that targeted therapy developers dream about. The chemogenomic framework makes such hypotheses testable at scale: rather than asking whether a single drug kills a single cell line, researchers can now ask where any new agent falls within the network of known damage-response dependencies.

The methodology itself deserves attention as a template. Chemogenomic mapping has matured into a discipline where perturbation libraries, high-content fitness assays, and computational embedding of interaction profiles generate maps with genuine predictive power. In this study, the authors systematically cross-referenced compound sensitivity profiles with gene perturbation data, using network inference to identify edges that classical pairwise screens would have missed. The PRDX1–iron connection is a proof of concept that such maps can surface biology that sits outside the conventional textbook divisions of the field—redox biochemistry emerging from a screen nominally designed to probe DNA repair.

There are, of course, caveats. Chemogenomic interactions describe statistical dependencies, and translating them into molecular mechanisms requires direct biochemical validation: measuring hydroxide radical generation, quantifying PRDX1 oxidation states during the damage response, and testing whether iron manipulation truly sensitizes PRDX1-deficient cells through the accumulation of double-strand breaks. The interaction maps are a hypothesis-generating engine, not a substitute for mechanism. But the strength of the approach lies precisely in its breadth—it surveys the whole terrain before anyone commits to digging a single hole, and it does so in a human cell context directly relevant to disease.

What emerges is a changed mental picture of genome maintenance. The DNA damage response has traditionally been drawn as a signaling diagram: kinases, adaptors, repair factors, and checkpoints connected by activation arrows. The chemogenomic map adds a chemical dimension to that diagram, weaving in iron pools, peroxide fluxes, and peroxidase capacity. A cell’s ability to survive a DNA break, in this view, depends not only on how fast it can find and repair the lesion but also on how well its redox buffers can contain the oxidative fallout that follows. PRDX1, sitting at the junction of those two requirements, now looks less like a background antioxidant and more like a strategic asset in the cell’s genome defense—raising the question of whether the next generation of cancer therapies will deliberately target the iron-damage axis to finish off tumors that have already been weakened by standard DNA-damaging treatment.

Subject of Research: A chemogenomic interaction map identifying a PRDX1-dependent axis linking iron metabolism and oxidative damage in the DNA damage response.

Article Title: Chemogenomic maps reveal a PRDX1-dependent iron–damage axis in the DNA damage response

Article References: O’Loughlin, T. A., Arab, A., Misiukiewicz, S., Montesano, E., Yogodzinski, C., Borah, A. A., Quarantotti, V., Lou, K., Rosen, B. S., Corn, J. E., Gianni, D., Kabir, S., Forment, J. V., & Gilbert, L. A. (2026). Chemogenomic maps reveal a PRDX1-dependent iron–damage axis in the DNA damage response. Nature Chemical Biology. https://doi.org/10.1038/s41589-026-02312-z

Image Credits: AI Generated

DOI: 10.1038/s41589-026-02312-z

Keywords: chemogenomics, DNA damage response, PRDX1, peroxiredoxin 1, iron metabolism, ferroptosis, reactive oxygen species, Fenton chemistry, genome maintenance, cancer therapy, redox biology, Nature Chemical Biology